Recently, many studies have reported the synthesis of ␤-hydroxyesters from the corresponding ketones (8, 11) . According to these studies, enzymatic reduction processes are the most efficient methods to obtain ␤-hydroxyesters with high optical purity. ␤-Hydroxyesters are useful for key pharmaceutical intermediates: L-carnitine from the (R)-enantiomer (19) and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor from the (S)-enantiomer (13) . Until now, some kinds of yeasts, fungi, and bacteria (1, 3, 13, 14, 15, 17, 18, 19) have been found to catalyze the asymmetric reduction of ethyl 4-chloro-3-oxobutyrate to ethyl (S)-or (R)-4-chloro-3-hydroxybutyrate. However, there has been little information about the enzyme which could reduce methyl 4-bromo-3-oxobutyrate (BAM) to methyl (S)-4-bromo-3-hydroxybutyrate [(S)-BHBM]. Because of its high chemical reactivity, BHBM would be easier to convert to an intermediate of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor than ethyl 4-chloro-3-hydroxybutyrate. Patel et al. reported the preparation of (S)-BHBM from BAM with whole cells of Geotrichum candidum (13) . However, G. candidum catalyzed the reduction of BAM to (S)-BHBM with a low enantiomeric excess (EE; 80%). Therefore, we have screened various kinds of microorganisms for the reduction of BAM to BHBM.
From 522 microorganisms (bacteria, 435 strains; yeast, 49 strains; fungi, 38 strains), 28 microorganisms (bacteria, 7 strains; yeast, 4 strains; fungi, 17 strains) which produced BHBM with a high EE (Ͼ80%) were selected in the first screening, and then five microorganisms were chosen in the second and third screenings ( Table 1 ). The first screening was performed in an aqueous system, but the second and third screenings were performed in a two-phase system of water-nbutyl acetate, because BAM was unstable in water but stable in some organic solvents. In the third screening, acetone-dried cells were adopted to select the organic solvent tolerant biocatalyst. From the screening, we found that Penicillium citrinum IFO4631 and Bacillus alvei IFO3343 could catalyze the reduction of BAM to optically active BHBM with more than 90% EE. P. citrinum IFO4631 showed (S)-selectivity for BAM. With regard to the coenzyme requirement, P. citrinum IFO4631 depended on NADPH, while NADH did not serve as a cofactor.
The NADPH-dependent alkyl 4-halo-3-oxobutyrate reductase (KER) was purified about 100-fold from the cell extract of P. citrinum by three steps of column chromatography with a yield of 0.1% ( Table 2 ). The purified KER showed a single band, with a molecular mass of about 39 kDa, on a sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel. The molecular mass of the native enzyme was 33 kDa by gel filtration. These data showed that KER was a monomeric protein.
The purified KER was digested with trypsin, and the digested peptides were separated by high-pressure liquid chromatography. Five peptides (S1 to S5) were isolated, and the amino acid sequences were determined by a protein sequencer. These peptides showed the following amino acid sequences: S1, NIMPVAYSPLGSQNQVP; S2, IPGVFGTFAS; S3, SIELS DADFEAINAVAK; S4, MIGVANYTIADLEK; and S5, YED-VLXXIDDSLKR. Comparison of the S1 sequence with proteins in databases revealed that it showed a strong similarity to the putative oxidoreductase gene of Gibberella zeae (6) . As the Nterminal amino acid sequence of native KER was not determined, the N-terminal amino acid of KER seemed to be blocked.
To isolate a cDNA clone encoding KER on the basis of its partial amino acid sequences, primer P1 (5Ј-TANGCNACNG GCATAATGTT-3Ј) for the internal amino acid sequence (S1) and primer SK (Stratagene, La Jolla, Calif.) for ZapII were FIG. 1. Sequence alignment of KER from P. citrinum with a closely related AKR family. From top to bottom in each set, the proteins are KER from P. citrinum, GCY protein from Saccharomyces cerevisiae (GCY1) (accession number P14065) (9), aldehyde reductase from Sporoboromyces salmonicolor (ALDX_SPOSA) (accession number P27800) (7), aldoketoreductase from S. cerevisiae (YPR1) (accession number Q12458) (10), D-arabinose dehydrogenase from S. cerevisiae (ARA1) (accession number P38115) (5), aldose reductase-related protein from Mus musculus (ALD1) (accession number P21300) (12) , and human aldose reductase (hADR) (accession number P15121) (16) . Dashed lines indicate gaps introduced for better alignment. Asterisks denote amino acids perfectly conserved in all seven proteins, and dots denote well-conserved amino acids. The similarities between KER and S. cerevisiae GCY protein, aldehyde reductase from S. salmonicolor, aldoketoreductase YPR1 from S. cerevisiae, D-arabinose dehydrogenase from S. cerevisiae, aldose reductase-related protein from Mus musculus, and human aldose reductase were 42, 38, 39, 39, 38, and 39%, respectively. , and the deduced amino acid sequence was identical to the partial amino acid sequences of KER determined by the peptide sequencing. The deduced molecular mass of KER was 36.6 kDa, which was similar to that estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A sequence identity search showed that KER had strong similarities with the proteins belonging to the aldoketoreductase (AKR) superfamily (4) (Fig. 1) . Although the primary structure of KER showed 82% identity to Aspergillus nidulans glycerol dehydrogenase (2), KER did not catalyze the dehydrogenation of glycerol. KER was classified as a new member of the yeast AKRs (AKR3E1) according to the updated AKR nomenclature system. An expression vector, pTrcKER, was constructed by inserting the whole ker gene into the NcoI/BamHI site of pTrc99A (Pharmacia Biotech, Uppsala, Sweden). Escherichia coli HB101 cells (pTrcKER) were cultured at 30°C in Luria-Bertani medium (1% tryptone, 0.5% yeast extract, and 0.5% NaCl [pH 7.0]) containing 0.05 mg of ampicillin/ml. For induction of the gene under the control of the trc promoter, 0.1 mM isopropyl-␤-D-thiogalactopyranoside (IPTG) was added to the Luria-Bertani medium. Washed cells obtained from 100 ml of culture broth were incubated in 30 ml of reaction mixture containing 1.5 mmol of potassium phosphate buffer (pH 6.5), 6.72 mmol of BAM, 0.021 mmol of NADP ϩ , 210 U of glucose dehydrogenase (Amano Pharmaceutical, Nagoya, Japan), 16.3 mmol of glucose, and 15 ml of n-butyl acetate. The mixture was vigorously stirred at 30°C. During the reaction, the pH of the mixture was adjusted to 6.5 by adding 2 M Na 2 CO 3 solution automatically. After an 11-h reaction, (S)-BHBM (79 g/liter) was accumulated in the organic solvent layer. The molar conversion yield and EE of (S)-BHBM were 88 and 96%, respectively. On the other hand, when we tested the recombinant E. coli cells in the water-n-butyl acetate two-phase system in the absence of BAM with shaking, approximately 70% of total KER activity liberated from the cells was found in the aqueous solution, and 90% of the total KER activity was found in the solution after a 4-h incubation, suggesting that n-butyl acetate damages the cell membrane to cause the release of proteins from the cells. Thus, the recombinant E. coli cells (pTrcKER) were confirmed to be a suitable biocatalyst to produce (S)-BHBM.
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